Terms: = Lymphoma AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
19 results:
1. An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
[TBL] [Abstract] [Full Text] [Related]
2. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.
Chen X; Wen F; Li Z; Li W; Zhou M; Sun X; Zhao P; Zou C; Liu T
Cancer Med; 2022 Sep; 11(18):3479-3490. PubMed ID: 35488386
[TBL] [Abstract] [Full Text] [Related]
3. 5-
Suksamai D; Racha S; Sriratanasak N; Chaotham C; Aphicho K; Lin ACK; Chansriniyom C; Suwanborirux K; Chamni S; Chanvorachote P
Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447911
[TBL] [Abstract] [Full Text] [Related]
4. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
[TBL] [Abstract] [Full Text] [Related]
5. Apigenin as an anticancer agent.
Imran M; Aslam Gondal T; Atif M; Shahbaz M; Batool Qaisarani T; Hanif Mughal M; Salehi B; Martorell M; Sharifi-Rad J
Phytother Res; 2020 Aug; 34(8):1812-1828. PubMed ID: 32059077
[TBL] [Abstract] [Full Text] [Related]
6. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract] [Full Text] [Related]
7. [Effects of hypoxia-inducible factor 1α on hypoxic tolerance of human amniotic mesenchymal stem cells].
Ge L; Yu D; Su R; Cao Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 Mar; 32(3):264-269. PubMed ID: 29806273
[TBL] [Abstract] [Full Text] [Related]
8. A p110δ-specific inhibitor combined with bortezomib blocks drug resistance properties of EBV-related B cell origin cancer cells via regulation of NF-κB.
Park GB; Chung YH; Jeong JY; Kim D
Int J Oncol; 2017 May; 50(5):1711-1720. PubMed ID: 28339079
[TBL] [Abstract] [Full Text] [Related]
9. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
[TBL] [Abstract] [Full Text] [Related]
10. Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells.
Oh SJ; Noh KH; Lee YH; Hong SO; Song KH; Lee HJ; Kim S; Kim TM; Jeon JH; Seo JH; Kim DW; Kim TW
Oncotarget; 2015 Nov; 6(37):40255-67. PubMed ID: 26517679
[TBL] [Abstract] [Full Text] [Related]
11. Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.
Wen Z; Feng S; Wei L; Wang Z; Hong D; Wang Q
Int J Mol Med; 2015 Dec; 36(6):1657-63. PubMed ID: 26497016
[TBL] [Abstract] [Full Text] [Related]
12. Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells.
Huber S; Huettner JP; Hacker K; Bernhardt G; König J; Buschauer A
PLoS One; 2015; 10(7):e0133743. PubMed ID: 26196503
[TBL] [Abstract] [Full Text] [Related]
13. Tumor formation and drug resistance properties of human glioblastoma side population cells.
Chen D
Mol Med Rep; 2015 Jun; 11(6):4309-14. PubMed ID: 25633829
[TBL] [Abstract] [Full Text] [Related]
14. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
[TBL] [Abstract] [Full Text] [Related]
15. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
[TBL] [Abstract] [Full Text] [Related]
16. Up-regulation of the embryonic self-renewal network through reversible polyploidy in irradiated p53-mutant tumour cells.
Salmina K; Jankevics E; Huna A; Perminov D; Radovica I; Klymenko T; Ivanov A; Jascenko E; Scherthan H; Cragg M; Erenpreisa J
Exp Cell Res; 2010 Aug; 316(13):2099-112. PubMed ID: 20457152
[TBL] [Abstract] [Full Text] [Related]
17. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility.
Nurmio M; Keros V; Lähteenmäki P; Salmi T; Kallajoki M; Jahnukainen K
J Clin Endocrinol Metab; 2009 Jun; 94(6):2119-22. PubMed ID: 19318447
[TBL] [Abstract] [Full Text] [Related]
18. Establishing a germ cell origin for metastatic tumors using oct4 immunohistochemistry.
Cheng L
Cancer; 2004 Nov; 101(9):2006-10. PubMed ID: 15386301
[TBL] [Abstract] [Full Text] [Related]
19. The clinical significance of serum CD8 antigen levels in adult patients with Hodgkin's disease.
Gause A; Verpoort K; Roschansky V; Tschiersch A; Hasenclever D; Schmits R; Diehl V; Brosteanu O; Pfreundschuh M
Ann Oncol; 1991 Sep; 2(8):579-83. PubMed ID: 1724380
[TBL] [Abstract] [Full Text] [Related]
